http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1514113-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_319eed6d6813db49e8057bdaa5e60233 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2405-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate | 2003-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91340286c8d969ab7586cff9bf0f7719 |
| publicationDate | 2006-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1514113-B1 |
| titleOfInvention | Method for diagnosing sepsis by determining anti-asialoganglioside antibodies |
| abstract | Early diagnosis or diagnosis of sepsis and systemic infections similar to sepsis, or assessing the danger of developing sepsis and similar infections in patients at risk, comprises determining the presence and/or amount of anti-asialo-GM1 antibodies (anti-AGM1-antibodies) in a biological fluid of the patient or the patient at risk. (A) Procedure for early diagnosis or diagnosis of sepsis and systemic infections similar to sepsis, for predicting the course of infection, for assessing the severity of infection, for determining the effectiveness of therapy, and for assessing the danger of developing sepsis and similar infections in a patient at risk, comprises determining the presence and/or amount of anti-asialo-GM1 antibodies (anti-AGM1-antibodies) in a biological fluid of the patient or the patient at risk, which portrays the presence and/or amount of cross-reacting antibodies. Independent claims are also included for the following: (B) procedure for quality control of donated blood for medical purposes; and (C) procedure for detecting individual substances or components of a substance mixture, for determining their structural characteristics, or for simulating ganglioside structure. |
| priorityDate | 2002-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 170.